Communications of the ACM

Tony Hoare and His Imprint on Computer Science

Had they included just one of Tony Hoare’s achievements, many scientific careers would be considered prestigious enough. His had a long list, unfortunately closed by his passing away at the age of 92 ...

The Most Important Idea In AI: Recursive Self Improvement

Recursive self improvement is the key to solving intelligence. Human intelligence is built on our ability to characterize the ...
Scientific American

Mathematicians find one pi formula to rule them all

Divide any circle’s circumference by its diameter and you get pi. But what, exactly, are its digits? Measuring physical ...
The Conversation

A few weeks of X’s algorithm can make you more right‑wing – and it doesn’t wear off quickly

Timothy Graham receives funding from the Australian Research Council (ARC) for the Discovery Project, 'Understanding and Combatting "Dark Political Communication"'. A new study published today in ...
The New York Times

Silicon Valley Wants to Build A.I. That Can Improve A.I. on Its Own

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...
InfoQ

MIT's Recursive Language Models Improve Performance on Long-Context Tasks

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Andres Almiray, a serial open-source ...
Seeking Alpha

Recursion Pharmaceuticals: Upgrading To Buy - My Most Surprising Call Of 2025

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Benzinga.com

Recursion Pharmaceuticals Stock Is Soaring Today: Here's Why

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...
Reuters

Recursion Pharma's AI-powered therapy reduces polyp growth in a rare disease trial

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...
IEEE

Comparative Analysis of Recursive Kalman Type Algorithms for Polynomial Filtering Problems

Many problems connected with processing of redundant measurement data have a nonlinear character. To solve these problems with in the stochastic approach, the developers apply different suboptimal ...
STAT

Recursion’s incoming CEO: Beyond hype on AI-driven drug development, it’s time to show results

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...